#U.S. Population Health Management market size

[laxmandige05]

The U.S. population health management market size was exhibited at USD 26.60 billion in 2022 and is projected to hit around USD 158.63 billion by 2032, growing at a CAGR of 19.55% during the forecast period 2023 to 2032. according to a new report by Nova One Advisor.

[laxmandige]

The U.S. Population Health Management market size was exhibited at USD 26.60 billion in 2022 and is projected to hit around USD 158.63 billion by 2032, growing at a CAGR of 19.55% during the forecast period 2023 to 2032.

[domberaj38]

According to Nova one advisor, the U.S. Population Health Management market size was valued at US$ 20.9 billion in 2021 and is expected to hit US$ 103.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 19.7% from 2022 to 2030.

[fatliberation]

they have a point though. you wouldn't need everyone to accommodate you if you just lost weight, but you're too lazy to stick to a healthy diet and exercise. it's that simple. I'd like to see you back up your claims, but you have no proof. you have got to stop lying to yourselves and face the facts

Must I go through this again? Fine. FINE. You guys are working my nerves today. You want to talk about facing the facts? Let's face the fucking facts.

In 2022, the US market cap of the weight loss industry was $75 billion [1, 3]. In 2021, the global market cap of the weight loss industry was estimated at $224.27 billion [2]. 

In 2020, the market shrunk by about 25%, but rebounded and then some since then [1, 3] By 2030, the global weight loss industry is expected to be valued at $405.4 billion [2]. If diets really worked, this industry would fall overnight. 

1. LaRosa, J. March 10, 2022. "U.S. Weight Loss Market Shrinks by 25% in 2020 with Pandemic, but Rebounds in 2021." Market Research Blog. 2. Staff. February 09, 2023. "[Latest] Global Weight Loss and Weight Management Market Size/Share Worth." Facts and Factors Research. 3. LaRosa, J. March 27, 2023. "U.S. Weight Loss Market Partially Recovers from the Pandemic." Market Research Blog.

Over 50 years of research conclusively demonstrates that virtually everyone who intentionally loses weight by manipulating their eating and exercise habits will regain the weight they lost within 3-5 years. And 75% will actually regain more weight than they lost [4].

4. Mann, T., Tomiyama, A.J., Westling, E., Lew, A.M., Samuels, B., Chatman, J. (2007). "Medicare’s Search For Effective Obesity Treatments: Diets Are Not The Answer." The American Psychologist, 62, 220-233. U.S. National Library of Medicine, Apr. 2007.

The annual odds of a fat person attaining a so-called “normal” weight and maintaining that for 5 years is approximately 1 in 1000 [5].

5. Fildes, A., Charlton, J., Rudisill, C., Littlejohns, P., Prevost, A.T., & Gulliford, M.C. (2015). “Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records.” American Journal of Public Health, July 16, 2015: e1–e6.

Doctors became so desperate that they resorted to amputating parts of the digestive tract (bariatric surgery) in the hopes that it might finally result in long-term weight-loss. Except that doesn’t work either. [6] And it turns out it causes death [7],  addiction [8], malnutrition [9], and suicide [7].

6. Magro, Daniéla Oliviera, et al. “Long-Term Weight Regain after Gastric Bypass: A 5-Year Prospective Study - Obesity Surgery.” SpringerLink, 8 Apr. 2008. 7. Omalu, Bennet I, et al. “Death Rates and Causes of Death After Bariatric Surgery for Pennsylvania Residents, 1995 to 2004.” Jama Network, 1 Oct. 2007.  8. King, Wendy C., et al. “Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery.” Jama Network, 20 June 2012.  9. Gletsu-Miller, Nana, and Breanne N. Wright. “Mineral Malnutrition Following Bariatric Surgery.” Advances In Nutrition: An International Review Journal, Sept. 2013.

Evidence suggests that repeatedly losing and gaining weight is linked to cardiovascular disease, stroke, diabetes and altered immune function [10].

10. Tomiyama, A Janet, et al. “Long‐term Effects of Dieting: Is Weight Loss Related to Health?” Social and Personality Psychology Compass, 6 July 2017.

Prescribed weight loss is the leading predictor of eating disorders [11].

11. Patton, GC, et al. “Onset of Adolescent Eating Disorders: Population Based Cohort Study over 3 Years.” BMJ (Clinical Research Ed.), 20 Mar. 1999.

The idea that “obesity” is unhealthy and can cause or exacerbate illnesses is a biased misrepresentation of the scientific literature that is informed more by bigotry than credible science [12]. 

12. Medvedyuk, Stella, et al. “Ideology, Obesity and the Social Determinants of Health: A Critical Analysis of the Obesity and Health Relationship” Taylor & Francis Online, 7 June 2017.

“Obesity” has no proven causative role in the onset of any chronic condition [13, 14] and its appearance may be a protective response to the onset of numerous chronic conditions generated from currently unknown causes [15, 16, 17, 18].

13. Kahn, BB, and JS Flier. “Obesity and Insulin Resistance.” The Journal of Clinical Investigation, Aug. 2000. 14. Cofield, Stacey S, et al. “Use of Causal Language in Observational Studies of Obesity and Nutrition.” Obesity Facts, 3 Dec. 2010.  15. Lavie, Carl J, et al. “Obesity and Cardiovascular Disease: Risk Factor, Paradox, and Impact of Weight Loss.” Journal of the American College of Cardiology, 26 May 2009.  16. Uretsky, Seth, et al. “Obesity Paradox in Patients with Hypertension and Coronary Artery Disease.” The American Journal of Medicine, Oct. 2007.  17. Mullen, John T, et al. “The Obesity Paradox: Body Mass Index and Outcomes in Patients Undergoing Nonbariatric General Surgery.” Annals of Surgery, July 2005. 18. Tseng, Chin-Hsiao. “Obesity Paradox: Differential Effects on Cancer and Noncancer Mortality in Patients with Type 2 Diabetes Mellitus.” Atherosclerosis, Jan. 2013.

Fatness was associated with only 1/3 the associated deaths that previous research estimated and being “overweight” conferred no increased risk at all, and may even be a protective factor against all-causes mortality relative to lower weight categories [19].

19. Flegal, Katherine M. “The Obesity Wars and the Education of a Researcher: A Personal Account.” Progress in Cardiovascular Diseases, 15 June 2021.

Studies have observed that about 30% of so-called “normal weight” people are “unhealthy” whereas about 50% of so-called “overweight” people are “healthy”. Thus, using the BMI as an indicator of health results in the misclassification of some 75 million people in the United States alone [20]. 

20. Rey-López, JP, et al. “The Prevalence of Metabolically Healthy Obesity: A Systematic Review and Critical Evaluation of the Definitions Used.” Obesity Reviews : An Official Journal of the International Association for the Study of Obesity, 15 Oct. 2014.

While epidemiologists use BMI to calculate national obesity rates (nearly 35% for adults and 18% for kids), the distinctions can be arbitrary. In 1998, the National Institutes of Health lowered the overweight threshold from 27.8 to 25—branding roughly 29 million Americans as fat overnight—to match international guidelines. But critics noted that those guidelines were drafted in part by the International Obesity Task Force, whose two principal funders were companies making weight loss drugs [21].

21. Butler, Kiera. “Why BMI Is a Big Fat Scam.” Mother Jones, 25 Aug. 2014. 

Body size is largely determined by genetics [22].

22. Wardle, J. Carnell, C. Haworth, R. Plomin. “Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment” American Journal of Clinical Nutrition Vol. 87, No. 2, Pages 398-404, February 2008.

Healthy lifestyle habits are associated with a significant decrease in mortality regardless of baseline body mass index [23].  

23. Matheson, Eric M, et al. “Healthy Lifestyle Habits and Mortality in Overweight and Obese Individuals.” Journal of the American Board of Family Medicine : JABFM, U.S. National Library of Medicine, 25 Feb. 2012.

Weight stigma itself is deadly. Research shows that weight-based discrimination increases risk of death by 60% [24].

24. Sutin, Angela R., et al. “Weight Discrimination and Risk of Mortality .” Association for Psychological Science, 25 Sept. 2015.

Fat stigma in the medical establishment [25] and society at large arguably [26] kills more fat people than fat does [27, 28, 29].

25. Puhl, Rebecca, and Kelly D. Bronwell. “Bias, Discrimination, and Obesity.” Obesity Research, 6 Sept. 2012. 26. Engber, Daniel. “Glutton Intolerance: What If a War on Obesity Only Makes the Problem Worse?” Slate, 5 Oct. 2009.  27. Teachman, B. A., Gapinski, K. D., Brownell, K. D., Rawlins, M., & Jeyaram, S. (2003). Demonstrations of implicit anti-fat bias: The impact of providing causal information and evoking empathy. Health Psychology, 22(1), 68–78. 28. Chastain, Ragen. “So My Doctor Tried to Kill Me.” Dances With Fat, 15 Dec. 2009. 29. Sutin, Angelina R, Yannick Stephan, and Antonio Terraciano. “Weight Discrimination and Risk of Mortality.” Psychological Science, 26 Nov. 2015.

There's my "proof." Where is yours?

[market-insider]

COVID-19 Pandemic Changed The Outlook Of U.S. Population Health Management Market

The U.S. population health management market size is expected to reach USD 103.7 billion in 2030, registering a CAGR of 19.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increase in healthcare expenditure, need for value-based healthcare delivery, and effective disease management across different care settings are among the key factors expected to drive the market during the forecast period.

In the U.S., poor healthcare management results in the loss of productivity and a significant portion of healthcare costs. Adoption of PHM software by employers helps in the management of their healthcare budget as they can keep a track of the employees’ health status. The market is likely to witness rapid growth in the coming years due to the growing demand for healthcare IT services and solutions that encourage healthcare delivery reliant on value, resulting in a transition from Fee-For-Service to a value-based payment model.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Population Health Management Market Report

Population health management is built on a Fee-for-Service (FFS) reimbursement method, wherein physicians and other healthcare providers are reimbursed by government agencies and insurance companies on basis of the number of services offered to patients. The new payment model allows reimbursement based on the quality of care delivered and provides comprehensive tools to handle financial and clinical risk for value-based care delivery.

The COVID-19 pandemic has changed the outlook of healthcare in the U.S. with the advanced use of web-based technology in healthcare. Healthcare providers are increasingly investing in PHM software to offer better outcomes. PHM can also be used for tracking the vital signs of patients discharged from hospitals, which can then be analyzed to offer meaningful insights into a patient’s health. The lockdown has disrupted the existing system and PHM systems are the current need to manage the patient population.

[kp777]

By Ralph Nader

Common Dreams

October 29, 2023

The message of Israeli peace groups’ peaceful solutions are drowned out by the media’s addiction to interviews with military tacticians.

In the midst of extensive coverage of the war in Gaza, there are questions that the U.S. mass media should address:

1. How did Hamas, with tiny Gaza surrounded by a 17-year Israeli blockade, subjected to unparalleled electronic surveillance, with spies and informants, and augmented by an overwhelming air, sea, and land military presence, manage to get these weapons and associated technology for their October 7 surprise raid?

2. What is the connection between the stunning failure of the Israeli government to protect its people on the border and the policy of Prime Minister Benjamin Netanyahu? Recall TheNew York Times (October 22, 2023) article by prominent journalist, Roger Cohen, to wit: “All means were good to undo the notion of Palestinian statehood. In 2019, Mr. Netanyahu told a meeting of his center-right Likud party: ‘Those who want to thwart the possibility of a Palestinian state should support the strengthening of Hamas and the transfer of money to Hamas. This is part of our strategy.’” (Note: Israel and the U.S. fostered the rise of Islamic Hamas in 1987 to counter the secular Palestine Liberation Organization (PLO)).

3. Why is Congress preparing to appropriate over $14 billion to Israel in military and other aid without any public hearings and without any demonstrated fiscal need by Israel, a prosperous economic, technological, and military superpower with a social safety net superior to that of the U.S.? USDA just reported over 44 million Americans struggled with hunger in 2022. This, in the midst of a childcare crisis. Should U.S. taxpayers be expected to pay for Netanyahu’s colossal intelligence/military collapse?

Under international law, Biden has made the U.S. an active “co-belligerent” of the Israeli government’s vocal demolition of the 2.3 million inhabitants in Gaza, who are mostly descendants of Palestinian refugees driven from their homes in 1948.

4. Why hasn’t the media reported on President Joe Biden’s statement that the Gaza Health Ministry’s body count (now over 7,000 fatalities) is exaggerated? All indications, however, are that it is a large undercount by Hamas to minimize its inability to protect its people. Israel has fired over 8,000 powerful precision munitions and bombs so far. These have struck many thousands of inhabited buildings—homes, apartments buildings, over 120 health facilities, ambulances, crowded markets, fleeing refugees, schools, water and sewage systems, and electric networks—implementing Israeli military orders to cut off all food, water, fuel, medicine, and electricity to this already impoverished densely packed area the size of Philadelphia. For those not directly slain, the deadly harm caused by no food, water, medicine, medical facilities, and fuel will lead to even more deaths and serious injuries.

Note that over three-quarters of Gaza’s population consists of children and women. Soon there will be thousands of babies born to die in the rubble. Other Palestinians will perish from untreated diseases, injuries, dehydration, and from drinking contaminated water. With crumbled sanitation facilities, physicians are fearing a deadly cholera epidemic.

Israel bombed the Rafah crossing on the Gaza-Egypt border. Only a tiny trickle of trucks are now allowed there by Israel to carry food and water. Fuel for hospital generators still remains blocked.

5. Why can’t Biden even persuade Israel to let 600 desperate Americans out of the Gaza firestorm?

6. Why isn’t the mass media making a bigger issue out of Israel’s long-time practices of blocking journalists from entering Gaza, including European, American, and Israeli journalists? The only television crews left are Gazan-residing Al Jazeera reporters. Israeli bombs have already killed 26 journalists in the Gaza Strip since October 7th. Is Israel targeting journalists’ families? Gaza bureau chief of Al Jazeera Wael Al-Dahdouh’s family was killed in an Israeli airstrike on Wednesday.

Historians remind us that in a gridlocked conflict over time, it is the most powerful party’s responsibility to lead the way to peace.

7. Why isn’t the mainstream U.S. media giving adequate space and voice to groups advocating a cease-fire and humanitarian aid? The message of Israeli peace groups’ peaceful solutions are drowned out by the media’s addiction to interviews with military tacticians. Much time and space are being given to hawks pushing for a war that could flash outside of Gaza big time. Shouldn’t groups such as Jewish Voice for Peace, the Arab-American Institute, Veterans for Peace, and associations of clergy have their views and activities reported?

8. Why is the coverage of the war overlooking the Geneva Conventions, the United Nations Charter, and the many provisions of international law that all the parties, including the U.S., have been violating? (See the October 24, 2023 letter to President Biden). Under international law, Biden has made the U.S. an active “co-belligerent” of the Israeli government’s vocal demolition of the 2.3 million inhabitants in Gaza, who are mostly descendants of Palestinian refugees driven from their homes in 1948. (See, Convention on the Prevention and Punishment of the Crime of Genocide).

9. What about the human-interest stories that would be revealing? For example: How do Israeli F-16 pilots feel about their daily bombing of the completely defenseless Gazan civilian population and its life-sustaining infrastructures? What are the courageous Israeli human rights and refuseniks thinking and doing in a climate of serious repression of their views as a result of Netanyahu’s defense collapse on October 7?

10. Where is the media attention on the statements from Israeli military commentators, who, for years have declared high-tech U.S.-backed, nuclear-armed Israel to be more secure than at any time in its history? Israel is reasserting its overwhelming military domination of the entire region, fully backed by U.S. militarism.

Historians remind us that in a gridlocked conflict over time, it is the most powerful party’s responsibility to lead the way to peace.

Establishing a two-state solution has been supported by Palestinians. All the Arab nations, starting with the Arab League peace proposal in 2002, support this solution as well. It is up to Israel and the U.S., assuming annexation of what is left of Palestine is not Israel’s objective. (See, the March 29, 2002 New York Times article: “Mideast Turmoil; Text of the Peace Proposals Backed by the Arab League”).

More media attention on this subject matter is much needed.

[health-views-updates]

2024 Compounding Pharmacies Market Dynamics: Trends and Insights

The global compounding pharmacies market is projected to witness steady growth over the next decade, with its market size expected to increase from USD 12.6 billion in 2023 to USD 19.9 billion by 2032. The market will experience a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2024 to 2032, driven by rising demand for personalized medications and tailored healthcare solutions.

Compounding pharmacies provide customized medications by combining, altering, or mixing ingredients to meet individual patient needs. These pharmacies are particularly beneficial for patients who require specific doses, alternative forms of medication, or allergen-free formulations that are not available in mass-produced pharmaceutical products. As the healthcare landscape shifts toward more personalized approaches, the compounding pharmacy industry is poised for consistent growth.

Get Free Sample PDF: https://www.snsinsider.com/sample-request/4513 

Key Market Drivers

Rising Demand for Personalized Medication: One of the primary growth drivers for the compounding pharmacies market is the increasing demand for personalized healthcare. Standard pharmaceutical products do not always meet the specific needs of every patient. Compounding pharmacies play a crucial role in filling this gap by offering custom formulations that cater to individual patient requirements, such as adjusting medication strengths, flavors, or delivery methods. This trend is especially prevalent in treating chronic conditions, hormone replacement therapies, and pediatric care.

Growth of Geriatric Population: The global aging population is a significant factor contributing to the expansion of the compounding pharmacies market. Older adults often require personalized medication solutions due to polypharmacy (the use of multiple medications) and the need for tailored dosages. Many elderly patients also face difficulties in swallowing pills, leading to a demand for liquid formulations or transdermal options that compounding pharmacies can provide.

Increasing Incidence of Chronic Diseases: The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer has further propelled the need for customized therapies. Compounding pharmacies are able to develop medications that are tailored to manage the symptoms of these conditions effectively. In addition, they can create formulations that address medication shortages or provide alternative treatments when commercial drugs are unavailable.

Regulatory Support and Innovations: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) are increasingly supporting the use of compounding pharmacies, provided they adhere to stringent quality standards. Regulatory initiatives, along with technological advancements in compounding techniques, are creating new opportunities for market growth. Innovations in drug delivery methods, automation, and formulation technologies are further enhancing the capabilities of compounding pharmacies to produce high-quality and safe medications.

Challenges and Market Opportunities

Despite the positive outlook, the compounding pharmacies market faces several challenges. Stringent regulatory frameworks and concerns over the safety and efficacy of compounded medications can hinder market growth. Compounding pharmacies must meet rigorous quality standards, and any lapses can affect public trust and demand for their services.

However, the increasing focus on patient-centric care, coupled with technological advancements in drug compounding, presents ample opportunities. Automation in compounding processes is reducing the risk of human error, while digital health solutions are making it easier for healthcare providers to prescribe customized medications. Additionally, the market is expected to see growth in veterinary compounding, as pet owners seek personalized treatments for their animals.

Regional Insights

North America remains the largest market for compounding pharmacies, driven by the presence of advanced healthcare infrastructure and a strong focus on personalized medicine. The United States, in particular, has a well-established regulatory framework that supports compounding pharmacies, leading to the proliferation of these services.

Europe is also witnessing steady growth, especially in countries like Germany, the UK, and France, where there is increasing awareness of the benefits of personalized medication. Meanwhile, the Asia-Pacific region is emerging as a key growth area due to its expanding healthcare sector, growing patient population, and increasing demand for customized treatments.

Future Outlook

The future of the compounding pharmacies market looks promising, as healthcare continues to move toward a more personalized and patient-centric model. With a projected CAGR of 5.2% from 2024 to 2032, the market is expected to see innovations in compounding technologies and broader adoption of custom medications across various therapeutic areas.

In conclusion, the global compounding pharmacies market, valued at USD 12.6 billion in 2023, is on track to reach USD 19.9 billion by 2032. With the rising demand for personalized medicine, the growth of the aging population, and advancements in compounding techniques, this market is set for significant expansion over the next decade.

Other Trending Reports

Dental Suction Systems Market

Cosmeceuticals Market

Cell Therapy Market

Growth Hormone Deficiency Market

[kathansky]

Global Animal Health Market: Size, Share, Growth, Industry Trends | 2024-2031

Leading market research firm SkyQuest Technology Group recently released a study titled 'Animal Health Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Animal Health report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Animal Health Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

The research analysis on the global Animal Health Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Animal Health Market circumstances in the forecast period between 2024 and 2031. The global Animal Health Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Animal Health Market has experienced robust growth over the past decade and is projected to continue expanding. Global Animal Health Market size was valued at USD 58.28 billion in 2022 and is poised to grow from USD 63 billion in 2023 to USD 117.48 billion by 2031, at a CAGR of 8.1% over the forecast period (2024- 2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/animal-health-market 

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Animal Health Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Animal Type

Production Animals (Poultry, Swine, Cattle, Sheep & Goats, Fish), Companion Animal (Dog, Cat, Horse, Others)

Product

Biologics (Vaccines [Modified/ Attenuated Live,Inactivated(Killed), Other Vaccines], Other Biologics), Pharmaceuticals (Parasiticides, Anti-Infectives, Anti -Inflammatory, Analgesics, other), Medicinal Feed Additives, Diagnostics (Consumables, Reagents and Kits,Instruments and Devices), Equipment & Disposables (Critical care Consumables, Anesthesia equipment, Temprature Management Equipment, Rescue & Resuscitation Equipment, Research Equipment, Patient Monitoring Equipment), Others (Veterinary Telehealth, Veterinary Software, Livestock Monitoring)

Distribution Channel

Retail, E-Commerce, Hospital/Clinic Pharmacy

End Use

Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics and Others

Get your customized report @ https://www.skyquestt.com/speak-with-analyst/animal-health-market 

Following are the players analyzed in the report:

Zoetis Inc. 

Merck Animal Health 

Elanco Animal Health 

Boehringer Ingelheim Animal Health 

Bayer Animal Health 

Virbac 

Ceva Santé Animale 

IDEXX Laboratories, Inc. 

Vetoquinol S.A. 

Dechra Pharmaceuticals PLC 

Neogen Corporation 

Phibro Animal Health Corporation 

Kindred Biosciences, Inc. 

Norbrook Holdings Limited 

Heska Corporation 

Nutreco N.V. 

AniCura AB 

PetIQ, Inc. 

Idexx Laboratories 

Petmed Express, Inc.

Regional Analysis 1. North America: - The United States and Canada dominate the North American Animal Health Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Animal Health consumption. 2. Europe: - Europe is a significant player, with major Animal Health Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Animal Health manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Animal Health Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Animal Health Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

Buy your full report: https://www.skyquestt.com/buy-now/animal-health-market 

[tamanna31]

Health Check-up Market - The Biggest Trends to watch out for 2023-2030

Health Check-up Industry Overview

The global health check-up market size was valued at USD 48.71 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030.

The market growth is attributable to the increasing prevalence of chronic diseases, rising investments from government bodies to establish population medical screening initiatives, and the adoption of telemedicine & home-based services. For instance, in May 2023, the Indian Health Ministry launched a medical screening initiative for people with hypertension and diabetes. This initiative will provide standard care to around 75 million people suffering from non-communicable diseases by 2025.

Gather more insights about the market drivers, restrains and growth of the Health Check-up Market

Moreover, the introduction of telemedicine in general healthcare practices fueled the home-based testing market, while the healthcare ecosystem's digital connectivity framework powered the health check-up market during the COVID-19 pandemic. The increasing prevalence of life-threatening diseases is one of the key drivers for the industry. Additionally, non-communicable diseases such as diabetes, hypertension, cancer, and cardiovascular diseases are increasing, which often remain asymptomatic in the early stages. For instance, as per an AMGA article, more than 30% of the U.S. population suffers from prehypertension, increasing the chances of developing high blood pressure. Regular health check-up allows individuals to manage the condition effectively, as only 1 in 4 U.S. adults have their hypertension under control.

Additionally, government bodies are undertaking initiatives to screen the target population for different medical conditions. For instance, the U.S. Preventive Services Task Force (USPSTF) recommends yearly screening for adults aged 18 and older to manage blood pressure risks. Similarly, Middle Eastern economies have initiated medical screening programs to raise awareness of the increasing hypertension prevalence. For instance, in May 2023, the Ministry of Health and Prevention (MoHAP) UAE launched a national campaign for the early detection of hypertension. By 2030, UAE plans to reduce the prevalence of high blood pressure by 30%. Hence, increasing recommendations from government bodies will be key drivers for the global market.

The global market is experiencing innovation driven by the adoption of digital technology in the healthcare ecosystem. In the Europe region, countries are integrating medical services to improve healthcare facilities across multiple countries, which is driving the need for digital technologies. For instance, in June 2022, Nordic countries launched Nordic Interoperability Project (NIP) which aims to enable healthcare service providers in Sweden, Denmark, Norway, Finland, and Iceland to evaluate an integrated digital medical ecosystem focused on self-management and preventive care. Additionally, a proposal from the European Commission in May 2022 plans to create a European Health Data Space, which will harness the medical data of nearly 450 million people, thereby establishing cross-border digital healthcare connectivity. Increasing health monitoring through digital platforms will increase the adoption of general & preventive tests over the forecast period.

The availability of health insurance coverage that includes preventive care benefits encourages individuals to undergo routine check-ups, thereby driving market growth. For instance, as per the U.S. CDC, private health insurance in the U.S. covers around 66% of the insured population. In recent years, there has been a shift in insurance policies to prioritize preventive care. Most insurance providers now include preventive care services, such as health check-ups, vaccinations, and screenings, as part of their coverage at no additional cost. Furthermore, insurance companies require policyholders to undergo medical risk assessments as part of the underwriting process. These assessments typically involve health check-ups and help insurers assess the individual's wellness and determine appropriate coverage and premiums. Hence, underwriting processes and growing awareness of preventive care are anticipated to drive market growth

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• The global cancer biopsy market size was valued at USD 30.05 billion in 2023 and is projected to grow at a CAGR of 8.11% from 2024 to 2030.

• The global pediatric allergy diagnostics market size was estimated at USD 2.44 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024 to 2030.

Key Health Check-up Company Insights

The key players operating in the health check-up industry are enhancing healthcare services and increasing strategic initiatives such as collaboration between government and private companies to enhance the efficiency and effectiveness of medical screening services. Moreover, the increasing introduction of direct-to-customer tests is further anticipated to fuel the market growth over the forecast period. For instance, in February 2023, Hurdel launched a Vitamin D test in the U.S., which will be sold on the company’s online store. Furthermore, the preventive test will allow the physicians to discuss concerns over chronic conditions and wellness. Some prominent players in global health check-up market include:

Quest Diagnostics Incorporated

Laboratory Corporation of America Holdings

SYNLAB International GmbH

OPKO Health, Inc. (BioReference Health, LLC.)

Eurofins Scientific

UNILABS

Sonic Healthcare Limited

ARUP Laboratories

Q2 Solutions

LalPathLabs.com

Order a free sample PDF of the Health Check-up Market Intelligence Study, published by Grand View Research.

[credenceresearchdotblog]

The Erythropoietin (EPO) drug Market is poised for substantial growth, with its market size projected to expand from USD 11,728.5 million in 2024 to USD 24,205.87 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.48%.The global erythropoietin (EPO) drugs market has experienced significant growth in recent years, driven by an increasing prevalence of anemia, particularly among patients with chronic kidney disease (CKD), cancer, and HIV. Erythropoietin, a glycoprotein hormone produced by the kidneys, plays a crucial role in the production of red blood cells (erythropoiesis). The synthetic forms of erythropoietin, known as erythropoiesis-stimulating agents (ESAs), are commonly used to treat anemia by stimulating the bone marrow to produce more red blood cells.

Browse the full report at https://www.credenceresearch.com/report/erythropoietin-drugs-market

Market Dynamics

The erythropoietin drugs market is primarily driven by the rising incidence of chronic diseases such as CKD and cancer. Anemia is a common complication in these diseases, leading to a growing demand for EPO drugs. According to the World Health Organization (WHO), anemia affects approximately 1.62 billion people globally, with iron deficiency anemia being the most prevalent type. This high prevalence, coupled with the increasing number of patients undergoing dialysis, chemotherapy, and antiretroviral therapy, is fueling the demand for EPO drugs.

The market is further bolstered by the growing geriatric population, which is more susceptible to chronic diseases and anemia. Additionally, advancements in biotechnology have led to the development of newer, more effective EPO formulations, enhancing treatment outcomes and expanding the market.

Regional Analysis

The erythropoietin drugs market is geographically segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

- North America: This region dominates the global market due to the high prevalence of CKD, well-established healthcare infrastructure, and the presence of major pharmaceutical companies. The U.S. is the largest market within this region, driven by a high rate of dialysis procedures and an aging population. - Europe: The market in Europe is also significant, with countries like Germany, the UK, and France leading due to their advanced healthcare systems and the widespread adoption of biosimilars.

- Asia-Pacific: This region is expected to witness the highest growth rate during the forecast period, attributed to a large patient population, increasing healthcare spending, and growing awareness about anemia management.

- Latin America and the Middle East & Africa: These regions are gradually emerging as potential markets due to improving healthcare infrastructure and increasing access to medical treatments.

Challenges and Opportunities

Despite the positive growth outlook, the erythropoietin drugs market faces several challenges. The high cost of biologics, side effects associated with EPO drugs, and stringent regulatory requirements are some of the key barriers to market growth. Additionally, the emergence of biosimilars poses competition to established biologics, potentially leading to price wars and reduced profit margins for manufacturers.

However, the market also presents significant opportunities. The development of next-generation EPO drugs with improved efficacy and safety profiles, coupled with the expanding applications of these drugs beyond anemia, could drive future growth. Moreover, the increasing focus on personalized medicine and targeted therapies is expected to open new avenues in the erythropoietin drugs market.

Key Player Analysis:

Amgen Inc.

Johnson & Johnson

F. Hoffmann-La Roche Ltd.

Pfizer Inc.

Novartis AG

Biocon Limited

Teva Pharmaceutical Industries Ltd.

Dr. Reddy’s Laboratories Ltd.

LG Life Sciences Ltd.

Wockhardt Ltd.

Segmentation:

by Drug Type 

Biologics

Biosimilars

by Product Type

Epoetin-alfa

Epoetin-beta

Darbepoetin-alfa

Others

by Application

Haematology

Kidney Disorder

Cancer

Others

by End User

Hospitals

Homecare

Specialty Clinics

Others

Browse the full report at https://www.credenceresearch.com/report/erythropoietin-drugs-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[industrynewsupdates]

Enteral Feeding Devices Market Key Drivers and Emerging Trends 2024-2030

The global enteral feeding devices market size was valued at USD 4.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2030. 

Growing geriatric population has resulted in increased incidences of diabetes, severe pancreatitis, and other gastrointestinal diseases, which aids market growth. Adoption of the “Feed Early Enteral Diet Adequately for Maximum Effect” (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse balloon designs are also expected to aid in growth during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Enteral Feeding Devices Market

Numerous NCBI studies suggest that people over 65 years pose a higher risk of developing chronic illnesses including Parkinson’s and nervous system disorders. The global population aged 60 years and older is expected to increase from around 1 billion in 2020 to about 1.4 billion in 2030 and is expected to double by 2050 to reach around 2.1 billion. The number of elderly patients with critical illnesses has increased significantly over the past few years. The risk of malnutrition and frailty among the geriatric population with comorbidities, such as stroke, depression, and dementia, is much higher, mainly owing to various age-related changes in body composition and muscle mass. This results in a reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of falls or injuries.

Enteral Feeding Devices Market Segmentation

Grand View Research, Inc. has segmented the global enteral feeding devices market report based on product, age group, indication, end-use, and region:

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Giving Set

• Enteral Feeding Pump

• Percutaneous Endoscopic Gastrostomy Device

• Low Profile Gastrostomy Device

• Nasogastric Tube

• Gastrostomy Tube

Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Adults 

• Pediatrics

Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Alzheimer’s

• Nutrition Deficiency

• Cancer Care

• Diabetes

• Chronic Kidney Diseases

• Orphan Diseases

• Dysphagia

• Pain Management

• Malabsorption/GI Disorder/Diarrhea

• Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

o Cardiology

o Neurology

o Critical Care (ICU)

o Oncology

o Others

• Home Care

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Spain `          

o Italy

o Russia

o Sweden

o Norway

o Denmark

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

o Singapore

• Latin America

o Brazil

o Mexico

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global surgical drills market size was estimated at USD 1.27 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030.

• The global ophthalmic ultrasound devices market size was valued at USD 590.9 million in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2030.

Key Companies & Market Share Insights

The market players are focusing on product development, new technological advancements, and other initiatives to strengthen their market position.

Key Enteral Feeding Devices Companies:

• Conmed Corporation

• C.R.Bard

• Cook Medical

• Boston Scientific Corporation

• Moog Inc.

• Fresenius Kabi AG

• Danone Medical Nutrition

• Kimberly-Clark

• Abbott Nutrition

• B Braun Melsungen AG

• Avanos Medical, Inc.

• Cardinal Health

• Applied Medical Technology, Inc.

• Vygon India

• Fidmi Medical

• ALCOR Scientific

• Amsino International, Inc.

Recent Developments

• In September 2023, Cardinal Health launched Kangaroo OMNI enteral feeding pump, intended to give patients undergoing enteral feeding more options to suit their individual needs over the course of their enteral feeding journey.

• In August 2023, Cardinal Health launched its next-generation NTrainerTM System 2.0, a medical device intended to shorten the length of stay in the neonatal intensive care unit (NICU) for premature and newborn infants by assisting them in developing the oral coordination skills necessary for the transition to independent feeding more quickly. The NTrainerTM System gives parents confidence in their newborns' progress and potential for success after discharge by giving clinicians the objective data they need to monitor an infant's development of pre-feeding skills through real-time assessment technology.

Order a free sample PDF of the Enteral Feeding Devices Market Intelligence Study, published by Grand View Research.

[industryforecastnews]

North America AREDS 2 Supplements Market To Reach USD 423.1 Million By 2030

North America AREDS 2 Supplements Market Growth & Trends

The North America AREDS 2 supplements market size is expected to reach USD 423.1 million by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The North America AREDS 2 supplements market is experiencing significant growth, driven by a combination of health trends, demographic shifts, and technological advancements. At the forefront of this growth is the increasing prevalence of chronic eye diseases, particularly Age-related Macular Degeneration (AMD). The AREDS 2 formula, which includes specific dosages of zinc, lutein, zeaxanthin, and various vitamins, has shown promising results in reducing the risk of disease progression and preserving functional vision, making it a go-to choice for those at risk or already affected by AMD.

Awareness about eye health and the benefits of supplements like AREDS 2 has grown substantially in recent years. This increased awareness, coupled with the widespread availability of these supplements over-the-counter and through various sales channels, including online platforms, has significantly boosted market growth. The COVID-19 pandemic has further accelerated this trend, with a notable increase in internet sales of eye health supplements. This shift in consumer behavior has made these products more accessible to a broader audience, contributing to the market's expansion.

Product innovation and new launches are playing a crucial role in driving the market forward. Companies in the sector are continuously developing new formulations to meet evolving consumer needs. For instance, in May 2024, EyePromise, a leading nutraceutical company specializing in eye health, unveiled the latest enhancements to its extensive nutritional program tailored for eyecare practices. Focused on innovation and enhancement, EyePromise has enhanced its AREDS 2-based products. These scientifically backed formulas will now be branded as Macular Health and Macular Health Complete.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/north-america-areds-2-supplements-market-report

North America AREDS 2 Supplements Market Report Highlights

North America AREDS 2 soft gels market accounted for a share of over 49% of the North Americas revenues in 2023. This innovative two-in-one soft gel addresses the needs of the aging population who are managing both age-related macular degeneration (AMD) and heart disease, offering a convenient solution that simplifies their supplement regimen. Leading companies are enhancing their product offerings with soft gels, which are favored for their ease of swallowing, precise dosage, and better absorption

The sales of North America AREDS 2 supplements through online distribution channels are projected to grow at a CAGR of 6.9% from 2024 to 2030. AREDS 2 supplements offered by most companies are available through Amazon, providing an online shopping option for those who prefer digital convenience. Companies prefer a multi-channel approach to enhance product availability and meet the diverse purchasing preferences of North American consumers. The COVID-19 pandemic further accelerated the shift towards online shopping as consumers prioritize health and safety

The AREDS 2 supplements market in the U.S. is projected to grow at a CAGR of 6.3% from 2024 to 2030. The market for AREDS 2 supplements in the U.S. is primarily driven by the growing awareness of age-related macular degeneration (AMD) and the desire for preventative measures among the aging population. AMD is a leading cause of vision loss among older adults, making it a significant public health concern

North America AREDS 2 Supplements Market Segmentation

Grand View Research has segmented the North America AREDS 2 supplements market on the basis of product, distribution channel, and country.

North America AREDS 2 Supplements Product Outlook (Revenue, USD Million, 2018 - 2030)

Capsules

Tablets

Soft gels

Others

North America AREDS 2 Supplements Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Pharmacies

Online

Others

North America AREDS 2 Supplements Country Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

List of Key Players in the North America AREDS 2 Supplements Market

Bausch + Lomb

Alcon Inc.

Nature Made (Pharmavite LLC)

EyePromise (ZeaVision, LLC)

MacuHealth

Viteyes (Vitamin Health, Inc.)

Codeage LLC

NATURELO Premium Supplements, LLC

NutraChamps Inc.

VISTA

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/north-america-areds-2-supplements-market-report

[trendingreportz]

FMCG Market - Forecast(2024 - 2030)

FMCG Market Overview

The FMCG market size is estimated to reach $16.2 billion by the year 2026 and is poised to grow at a CAGR of 6.7% during the forecast period of 2021-2026. FMCG refers to Fast Moving Consumer Goods, or also known as consumer-packaged goods. As the name is derogatory, all the goods included in this market have a short shelf life, and the consumer's daily need items are mostly up on the shelves. Owing to the fast rotation of goods, it becomes elementary to have superior supply chain management. Moreover, vendor-managed inventory offers better prospects to the distribution channels as they are skilled in that same domain. Consumer grocery items, along with certain home care items, make the FMCG segment whole. Moreover, manufacturers are now putting dietary supplements along with over-the-counter medicines under the head of FMCG, as they are of utmost importance to the current generation owing to their nutritional benefits. The customization and altered product offerings to different segments of the society, along with lucrative marketing strategies, are some of the factors driving the FMCG industry forward during the forecast period of 2021-2026.

Report Coverage

The report: “FMCG Market Forecast (2021-2026)”, by Industry ARC covers an in-depth analysis of the following segments of the FMCG Market.

By Product Type- Food and Beverages, Personal Care, Health Care, Home Care, and Consumer Electronics.

By Distribution Channel- Offline Stores and Online Stores.

By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa)

Request Sample

Key Takeaways

North American market, held a dominant revenue share in the year 2020. It is owing to high disposable income, concentrated population density, and modernization to adopt branded products that are offered by the FMCG segment. Asia-Pacific shows optimal growth opportunities for the manufacturers. It is owing to the growing middle class, premiumization, and lastly, changing lifestyle.  

The demand for FMCG products will be driven by the customization and altered customer product offerings to the target market. However, poor relative servicing is a challenge faced by the FMCG industry.

Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the FMCG report.

FMCG Market Segment Analysis- By Product Types

The FMCG market based on product types can be segmented into food and beverages, personal care, health care, home care, and consumer electronics. The food and beverages segment held a dominant share in the year 2020. It is owing to a vast list of products offerings and alterations created by the various companies operating. Beverages are not just limited to water, tea, or any other former items. It incorporates multiple new inventions, which help the consumer attain the nutritional benefits and not compensate for the tastes.

Moreover, the food and beverages segment is estimated to be the fastest-growing segment, with a CAGR of 7.5% over the forecast period of 2021-2026. It is owing to the rising population of millennials and the preferential shift toward obtaining their diet from vegan products. 1 in 3 food products launched in the UK are now vegan. More importantly, the ready-to-go, with high nutrition content, is seeing a compelling demand.

Inquiry Before Buying

FMCG Market Segment Analysis- By Distribution Channel

The FMCG market based on distribution channels can be segmented into offline and online stores. The offline stores held the largest market share in the year 2020. It is owing to the property and characteristics of the offline stores to display multiple items on the shelves to create a sale. As a result, consumers are better positioned to understand the product characteristics and gain additional discounts when offline stores post their purchases.

However, online stores are estimated to be the fastest-growing segment, with a CAGR of 8.1% over the forecast period of 2021-2026. It is owing to better customer relationship management tools now incorporated by the companies to gain a hold on their regular customers. As a result, regular customers are offered discounts, cashback, and other benefits on the website. Additionally, the retail margin goes down while offering the products online. For example, Tata Tea Gold costs INR 625 in hypermarkets but costs INR 483 in online stores. 

FMCG Market Segment Analysis- By Geography

The FMCG market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. Geographically, Asia-Pacific held the largest share of 34% as compared to the other regions. It is owing to the robust supply management systems and reliance on vendor-managed inventories, which in turn reduces the damages and induces rapid consumption without the inclination of prices. Asia-Pacific also offers lucrative growth opportunities to the FMCG market. It is owing to the increasing young population in regions such as India and China. For example, India has a 65% young population, with education systems revamping, the consumption of packaged goods is bound to increase. Government initiatives supporting the manufacturing abilities while increasing the consumers' spending ability will act as a key reason for this region.

Schedule a Call

FMCG Market Drivers

Augmentation of Big-Data Analytics in the FMCG Market is helping to understand the needs of customers.

Big- Data analytics has been a prevalent discipline used across the industries. The latest advent of the analytical tool in the FMCG segment has helped the product manufacturers to comprehend consumer needs. The facts are more evident than the survey is what the FMCG companies believe. For example, Coco-Cola launched the program with Hewlett Packard by the name of “Share a Coke,” the analytical tools helped estimate the target audience for the program, and specific label coke bottles were rolled out to consumers. The following year Coco Coal recorded a 19% sales growth. Moreover, the customized offers entail the consumers to feel privileged and opt for buying that product.

The promotion of sustainable product offerings is helping the FMCG market to gain traction.

Consumers have become more concerned about the climatic changes and how their daily routines hamper the environment in matters more than one. As a result, product manufacturers focus on providing the desired goods in an optimal package, which is either reusable or recyclable. Moreover, in the UK, supermarkets contribute to 810,000 tonnes of throwaway packaging, which is hampering the environment. To counter the move, Tesco, the first retailer in the UK, announced removing plastic-wrapped multipacks from its offerings altogether. The following activities will result in the elimination of 350 tonnes of plastic annually.

Moreover, a plant-based diet has been given preference all over the world owing to sustainability. The manufacturers readily accepted the following interest, and now, 1 in 3 products offered are vegan. While producing FMCG goods, energy efficiency is another issue that the brands adopt and involve the public in the aftermath.

FMCG Market Challenges

The hindrance created in sales owing to providing relative servicing.

Mostly, in the FMCG market, several brands happen to take the shelves of the retail store. Hence, it becomes essential to offer product differentiation and offering of one brand over the other. Relative Servicing addresses the value provided in contrast with the competition. According to a study conducted by 155 brands, when the relative servicing is not appropriate, the brands performed 81% of their average. While, at the place where the relative servicing was reasonable, the brands registered a 1.2x increase in the revenue.

The lack of skills pertaining to reading the market by the sales professionals is a ready challenge faced by the FMCG Industry. 

The responsibility of the sales professionals in the field becomes of utmost importance. And if their skills and knowledge cannot capture the prevailing trends and explain the same to the consumer, the overall sales go down. If the companies don’t know the on-field consumer wants and reactions, the offerings cannot be customized, and the deals are hampered. The consumer behavior is dynamic, and the FMCG brand, which is fluent in capturing the so-called trend, will prevail in the market. Companies often hire professionals to ease the marketing process but do not check their knowledge to gain customer insights and wants. Failing to which, the customer doesn’t become their “premium” consumer.

Buy Now

FMCG Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Phytol Market. The top 10 FMCG Companies include:

Nestle AG

Procter and Gamble

PepsiCo

Unilever

Coca-Cola Company

Philip Morris International

AB- InBev

JBS

British American Tobacco

Heineken

Product Launches and Partnerships

In September 2021, Procter and Gamble launched Febreze Unstoppables Touch Fabric Spray. The following spray is designed to be used on soft surfaces or hard-to-wash surfaces throughout one’s home. Moreover, it uses touch-activated scent technology.

In June 2021, Carnation Breakfast Essentials announced its partnership with Kellogg’s and General Mills to create four cereal-inspired drinks cum beverages. Froot Loops, Krave, Frosted Flakes, and Gold Graham are the flavors launched. The objective of the beverage was to provide a drink with a taste of oven-baked cinnamon roll without any additives or flavors.

[heathcareforallworld]

Emerging Trends in the Beta Hydroxybutyrate Testing Industry

Introduction

Beta hydroxybutyrate (BHB) testing is a critical component in the assessment of metabolic states such as ketosis, diabetic ketoacidosis, and certain metabolic disorders. With the increasing prevalence of diabetes and a growing interest in ketogenic diets, the demand for BHB testing has surged. This article explores the size, share, industry trends, and future forecast of the Beta Hydroxybutyrate Testing Market up to 2032.

Market Size and Share

The Beta Hydroxybutyrate Testing Market has shown robust growth in recent years, driven by advancements in diagnostic technologies and an increasing awareness of metabolic health. Beta hydroxybutyrate testing Market Size was estimated at 2.34 (USD Billion) in 2023. The Beta Hydroxybutyrate Testing Market Industry is expected to grow from 2.57(USD Billion) in 2024 to 5.5 (USD Billion) by 2032. The beta hydroxybutyrate testing Market CAGR (growth rate) is expected to be around 9.96% during the forecast period (2024 - 2032).

North America holds the largest market share, followed by Europe and the Asia-Pacific region. Factors such as high healthcare expenditure, the prevalence of diabetes, and an increasing number of health-conscious consumers contribute to North America's dominance in the market.

Industry Trends

Technological Advancements: Innovations in BHB testing technologies, such as the development of non-invasive and rapid testing methods, have significantly enhanced the accuracy and convenience of these tests. Portable and home-testing kits are gaining popularity among consumers who seek continuous monitoring of their ketone levels.

Growing Prevalence of Diabetes: The rising incidence of diabetes globally has led to an increased demand for BHB testing. Diabetic patients require regular monitoring of their ketone levels to prevent complications such as diabetic ketoacidosis (DKA).

Popularity of Ketogenic Diets: The ketogenic diet, known for its potential benefits in weight loss and metabolic health, has spurred interest in BHB testing among health enthusiasts. Individuals on a ketogenic diet often use BHB tests to ensure they are in a state of ketosis.

Awareness and Education: Increased awareness and education regarding metabolic health and the importance of monitoring ketone levels have contributed to market growth. Health professionals are emphasizing the role of BHB testing in managing conditions like diabetes and obesity.

Regulatory Approvals: The market has witnessed a series of regulatory approvals for new BHB testing products, ensuring safety and efficacy. These approvals have instilled confidence among healthcare providers and consumers, further driving market growth.

Market Segmentation

The Beta Hydroxybutyrate Testing Market is segmented based on product type, application, end-user, and region.

By Product Type:

Blood Testing Devices

Urine Testing Devices

Breath Testing Devices

By Application:

Diabetes Management

Ketogenic Diet Monitoring

Sports and Fitness

Research and Diagnostics

By End-User:

Hospitals and Clinics

Diagnostic Laboratories

Homecare Settings

Research Institutions

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

Regional Analysis

North America: Dominates the market due to a high prevalence of diabetes, advanced healthcare infrastructure, and increased health consciousness among the population. The U.S. is a significant contributor to the regional market, driven by technological advancements and a high adoption rate of ketogenic diets.

Europe: Holds the second-largest market share, with countries like Germany, the UK, and France leading the market. The increasing number of diabetic patients and rising awareness of metabolic health are key factors driving the market in this region.

Asia-Pacific: Expected to witness the highest growth rate during the forecast period. Factors such as a large diabetic population, increasing healthcare expenditure, and growing awareness about metabolic disorders contribute to market growth in this region. Countries like China, India, and Japan are the major markets.

Latin America and Middle East & Africa: These regions are also expected to show significant growth, driven by improving healthcare infrastructure and rising awareness of metabolic health issues.

Competitive Landscape

The Beta Hydroxybutyrate Testing Market is highly competitive, with key players focusing on product innovation and strategic partnerships to gain a competitive edge. Major players in the market include:

Abbott Laboratories: Known for its Freestyle Precision Neo Blood Ketone Testing System, Abbott Laboratories is a leader in the BHB testing market.

Nova Biomedical: Offers the Nova Max Plus, a device that measures both blood glucose and ketone levels.

EKF Diagnostics: Provides a range of BHB testing products for clinical and home use.

Apex Biotechnology Corp.: Known for its innovative BHB testing devices, targeting both professional and consumer markets.

Future Prospects and Opportunities

The Beta Hydroxybutyrate Testing Market is poised for substantial growth over the next decade. Key opportunities include:

Expansion in Emerging Markets: Increasing healthcare awareness and improving infrastructure in emerging markets present significant growth opportunities for BHB testing products.

Product Development: Continued innovation in non-invasive testing methods and the development of multi-functional devices will drive market growth.

Telehealth Integration: The integration of BHB testing with telehealth platforms will enhance remote monitoring capabilities, providing convenience to patients and healthcare providers.

Collaborations and Partnerships: Strategic collaborations between diagnostic companies and healthcare institutions will facilitate the development of advanced testing solutions and expand market reach.

Conclusion

The Beta Hydroxybutyrate Testing Market is set to experience robust growth, driven by technological advancements, increasing prevalence of diabetes, and rising awareness of metabolic health. With significant opportunities in emerging markets and continued innovation in testing technologies, the market is well-positioned for a prosperous future. Stakeholders in the industry must focus on strategic partnerships and product development to capitalize on the growing demand for BHB testing.

[neha24blog]

U.S. Population Health Management Market Overview By Product, End-use And Forecast To 2030   : Grand View Research Inc.

San Francisco, 30 July 2024: The Report U.S. Population Health Management Market Size, Share & Trends Analysis Report by Product (Software, Services), By End Use (Providers, Payers, Employer Groups), And Segment Forecasts, 2023 – 2030 The U.S. population health management market size is expected to reach USD 103.7 billion in 2030, registering a CAGR of 19.54% from 2023 to 2030, according to a…

[herwolfnight]

U.S. Pharmacy Market Size, Share, and Trends: Detailed Insights

"The u.s. pharmacy market share was valued at USD 534.21 billion in 2020 and is projected to expand at a CAGR of 6.3% from 2020 to 2028, reaching USD 861.67 billion by 2028". This growth underscores substantial opportunities in this rapidly expanding, high-volume industry. The report offers a comprehensive analysis of the overall market conditions, trends, regional insights, opportunities, key players, and market segmentation, delivering crucial information for business success.

Get free Report Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/106306

The report presents detailed market segmentation, a systematic overview of key players, supply chain dynamics, consumer trends, and insights into emerging geographical markets. It provides an in-depth analysis of major market developments and competitor analysis, highlighting significant competitors to help businesses gain a comprehensive understanding of the market and products, enabling them to craft superior strategies. The team at Fortune Business Insights is committed to understanding clients' businesses and needs to deliver exceptional market research. This report is uniquely tailored to meet specific business requirements, making it highly relevant and commendable.

U.S. Pharmacy Market Key Attributes:

Report Attribute

Details

Forecast Period

2021 - 2028

Estimated Market Value (USD) in 2020

USD 534.21 billion

Forecasted Market Value (USD) by 2028

USD 861.67 billion

Compound Annual Growth Rate

6.3%

Report Type

Global

Our report explores various sectors, from pharmaceuticals to medical devices, offering stakeholders actionable intelligence to navigate and thrive in this dynamic market. Whether you are a healthcare provider, investor, or policymaker, our research equips you with the knowledge necessary to make informed decisions and drive innovation in the ever-evolving healthcare sector.

Top 10 Major Competitors of the of U.S. Pharmacy Market:

CVS Health Corporation (Rhode Island, U.S.)

Walgreens Boots Alliance, Inc. (Illinois, U.S.)

Cigna (Express Scripts) (Connecticut, U.S.)

UnitedHealth Group (Optum) (Minnesota, U.S.)

Walmart Inc. (Arkansas, U.S.)

The Kroger Company (Ohio, U.S.)

Rite Aid Corporation (Pennsylvania, U.S.)

Albertsons Companies, Inc. (Idaho, U.S.)

U.S. Pharmacy Market Key Drivers:

Increasing demand for prescription and over-the-counter medications due to aging population and chronic disease prevalence.

Technological advancements in pharmaceutical manufacturing, distribution, and dispensing, enhancing efficiency and accessibility.

Rising healthcare expenditure and insurance coverage driving pharmaceutical spending and retail pharmacy sales.

Expanding scope of pharmacy services, including medication therapy management, immunizations, and point-of-care testing.

Regulatory changes and healthcare reforms shaping pharmacy practice, reimbursement models, and drug pricing policies.

Here are some key elements of the u.s. pharmacy market 2024-2030 strategy:

Define the Research ObjectivesThe first step in the u.s. pharmacy market strategy is to clearly establish the research objectives. This involves pinpointing the specific questions that need to be answered and the information required. Clear objectives will steer the entire research process, ensuring the data collected is relevant and useful.

Identify the Target MarketBusinesses must pinpoint their target market and understand their needs, preferences, and behaviors. This involves segmenting the market based on factors such as demographics, psychographics, and geographic location. A thorough understanding of the target market allows for products, services, and marketing efforts to be effectively tailored to meet customer needs.

Select the Research MethodologyChoosing the right research methodology is crucial for gathering accurate and relevant data. Various methodologies, including surveys, focus groups, and observational research, can be employed. The chosen methodology should align with the research objectives and the type of data needed.

Collect DataWith the research methodology selected, data collection can commence using techniques such as online surveys, phone interviews, or in-person focus groups. Ensuring that the data collected is reliable, valid, and representative of the target market is essential for making informed decisions.

Analyze the DataAfter data collection, the next step is to analyze the data to identify trends, patterns, and insights. This analysis can involve statistical methods for quantitative data or qualitative techniques for open-ended responses. Proper data analysis is critical for drawing meaningful conclusions.

Draw Conclusions and Make RecommendationsBased on the data analysis, businesses can draw conclusions and make informed recommendations for future actions. These recommendations might include changes to product offerings, marketing strategies, or business operations. The goal is to use the insights gained from the research to drive business improvements and growth.

Continuously Monitor and AdaptMarkets are dynamic and constantly evolving. Therefore, it is important for businesses to continuously monitor their performance and adapt their strategies as needed to remain competitive. This ongoing process of monitoring and adaptation ensures that businesses can respond to market changes and emerging trends effectively.

Speak to Analyst for Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/106306

The u.s. pharmacy market report equips investors with the tools to enhance decision-making, explore a variety of investment opportunities, and achieve their financial objectives more efficiently. Moreover, the u.s. pharmacy market industry is experiencing rapid growth, fueled by factors detailed in the report, with significant expansion anticipated during the forecast period.

Our report offers valuable insights for stakeholders, including healthcare providers, policymakers, and investors, enabling them to make informed decisions and capitalize on market trends. Through comprehensive analysis and data-driven insights, we aim to assist stakeholders in navigating the complexities of the healthcare sector, fostering innovation, and achieving improved patient outcomes and sustainable growth.

Table of Content u.s. pharmacy market: 

Introduction u.s. pharmacy market

Research Scope u.s. pharmacy market

Market Segmentation u.s. pharmacy market

Research Methodology u.s. pharmacy market

Definitions and Assumptions u.s. pharmacy market

Executive Summary u.s. pharmacy market

Market Dynamics u.s. pharmacy market

Market Drivers u.s. pharmacy market

Market Restraints u.s. pharmacy market

Market Opportunities u.s. pharmacy market

Key Insights u.s. pharmacy market

Key Industry Developments - Merger, Acquisitions, and Partnerships U.S. Pharmacy Market

Porter’s Five Forces Analysis u.s. pharmacy market

SWOT Analysis u.s. pharmacy market

Technological Developments u.s. pharmacy market

Value Chain Analysis u.s. pharmacy market

TOC Continued…!

Quick Buy - U.S. Pharmacy Market Report: https://www.fortunebusinessinsights.com/checkout-page/106306

Key questions answered in this report

Q.1. What is the estimated U.S. Pharmacy Market size and growth rate for 2032?

Q.2. What are market trends of the U.S. Pharmacy Market?

Q.3. What factors are fueling the growth of this U.S. Pharmacy Market?

Q.4. What challenges are facing the U.S. Pharmacy Market?

Q.5. Who are the primary key players in this market?

Q.6. What threats and opportunities do these key players encounter?